Indefinite Delivery Contract SPE2DU25D1105

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,999,999.00, will provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet, through the Pharmaceutical Prime Vendor Global Program...
The Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and Naval Fleet. This unrestricted, single-award contract has an estimated total value of $30.3 billion over a 30-month base period...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. This is an unrestricted, fully competitive acquisition using a Lowest Price Technically Acceptable (LPTA)...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The $999,999,999 IDC has a base period of 30 months and three 30-month option periods, running through November 2036. The contract is intended to establish Prime Vendor...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The purpose of this contract is to establish Prime Vendor Contracts for the Pharmaceutical...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a 30-month base period and three 30-month option periods, running through December 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including...
The Indefinite Delivery Contract (IDC) SPE2DR25D1004 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The...
The Indefinite Delivery Contract (IDC) SPE2DU25D5141 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The $999,999,999 contract has a 30-month base period and three 30-month option periods, totaling an estimated value of $30.3 billion. This IDC aims to establish Pharmaceutical Prime Vendor Global Program Generation V...
The indefinite delivery contract (IDC) SPE2DR25D1007 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The $9,999,999,999 single-award IDC has a 30-month base period with three 30-month option periods, totaling an estimated $30.3 billion in value. The contract...
This Indefinite Delivery Contract (IDC) award, valued at $999,999,999, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses a broad spectrum of critical medical commodities including...

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The IDC will establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), which covers the provision of brand-name, generic, and specialty pharmaceuticals, as well as other pharmaceutical-related products, to support normal day-to-day operations, contingency planning, and war readiness for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is structured as a firm-fixed price, requirements-type contract, with a Lowest Price Technically Acceptable (LPTA) evaluation method. The government intends to make multiple primary supplier awards across four geographic regions and one award for a backup supplier, ensuring diversification of pharmaceutical sources to enhance resiliency during contingencies.

Generated 7/1/25, 12:34 PM